MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MP-23-0028279
_PRIVATE_LIMITED.webp)
Zefe Labs (I) Private Limited - pharma in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹17.05 Cr
▼ 32% YoY
Net profit · FY 2025
₹8.19 Lakh
Net margin 0.5%
EBITDA · FY 2025
₹47.02 Lakh
EBITDA margin 2.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹4.39 Cr
Satisfied ₹4.6 Cr
Company age
19 yrs
Est. 2007
Directors on board
3
As per MCA filings
About Zefe Labs (I) Private Limited
Data last updated:
Zefe Labs (I) Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 25 April 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74110MP2007PTC019484. Its GSTIN is 23AAACZ3712B1ZY (Madhya Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Gurmeet Singh Toor (Whole-Time Director) and Sukhwinder Kaur Toor (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 206 Sapphire Heights Plot No.12 A.B.Road Opposite Malhar Garden, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.05 Cr, a decline of 32% compared to the previous year. For the same year it recorded a net profit of ₹8.19 Lakh (net margin 0.5%) and EBITDA of ₹47.02 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 1% over five years.
The company is associated with 1 brand: Shagun. As per MCA filings, the company has open charges of ₹4.39 Cr and satisfied charges of ₹4.6 Cr on record.
Zefe Labs (I) Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0028279). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website oilin.in.
Company Details of Zefe Labs (I) Private Limited
CIN U74110MP2007PTC019484
Registration Number 019484
Incorporation Date 25 April 2007
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MP-23-0028279
CIN History of Zefe Labs (I) Private Limited
Zefe Labs (I) has one previous CIN (Corporate Identification Number): U72200MP2007PTC019484. The current CIN is U74110MP2007PTC019484, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74110MP2007PTC019484 | Current |
| U72200MP2007PTC019484 | Previous |
Key People
Gurmeet Singh Toor Whole-Time Director Sukhwinder Kaur Toor Whole-Time Director Manjit Singh Bhullar Whole-Time Director Recognitions & Rankings of Zefe Labs (I)
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address206 Sapphire Heights Plot No.12 A.B.Road Opposite Malhar Garden, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, API Manufacturers
Comprehensive company report
Zefe Labs (I) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Zefe Labs (I) Private Limited
Zefe Labs (I) operates one associated brand: Shagun. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical outsourcing firm providing API, pellets, and ingredients to manufacturers. | shagunpharma.com |
Business Activity of Zefe Labs (I) Private Limited
The main business activity of Zefe Labs (I) is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Zefe Labs (I) Private Limited FY 2025 filings available
Zefe Labs (I) Private Limited reported revenue of ₹17.05 Cr (down 32% YoY) for FY 2025.
Revenue · FY 2025
₹17.05 Cr ▼ 32%
Net profit · FY 2025
₹8.19 Lakh margin 0.5%
EBITDA · FY 2025
₹47.02 Lakh margin 2.8%
Compounded Annual Growth Rate (CAGR) of Zefe Labs (I) Private Limited
Revenue CAGR growth
1 year
▼ 32%
3 years · compounded
▼ 14%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▲ 16%
3 years · compounded
▼ 11%
5 years · compounded
▲ 10%
Revenue fell 32% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Zefe Labs (I) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹47.02 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.19 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Zefe Labs (I) Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Zefe Labs (I) are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Zefe Labs (I) Private Limited
Zefe Labs (I) has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gurmeet Singh Toor | Whole-Time Director | 28 Nov 2009 | 16 Years 10 Months | Current |
| Sukhwinder Kaur Toor | Whole-Time Director | 25 Apr 2007 | 19 Years 5 Months | Current |
| Manjit Singh Bhullar | Whole-Time Director | 28 Nov 2009 | 16 Years 10 Months | Current |
Peer Comparison of Zefe Labs (I) Private Limited
Zefe Labs (I) Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (API Manufacturers, Aromatics). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sreepathi Lab Private Limited | ₹17.28 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Nalgonda, Telangana, India |
| Rangodadhi Chemicals Private Limited | ₹17.2 Cr (FY 2025) | •••• | •••• | -18.0% | •••• | Ahmedabad, Gujarat, India |
| Three A Chemie Private Limited | ₹17.19 Cr (FY 2024) | •••• | •••• | -50.0% | •••• | |
| Hermes Laboratories Private Limited | ₹17.16 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Doddaballapur, Karnataka, India |
| Seth Brothers (Perfumers ) Private Ltd | ₹17.1 Cr (FY 2024) | •••• | •••• | 9.0% | •••• | Delhi, India |
| Zefe Labs (I) Private Limited this company | ₹17.05 Cr (FY 2025) | •••• | •••• | -32.0% | •••• | Indore, Madhya Pradesh, India |
| Cropel Lifesciences Private Limited | ₹16.99 Cr (FY 2024) | •••• | •••• | -22.0% | •••• | Kalol, Gujarat, India |
| Arkgen Pharma Private Limited | ₹16.92 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Bangalore, Karnataka, India |
| MNR Labs Private Limited | ₹16.89 Cr (FY 2025) | •••• | •••• | -44.0% | •••• | Hyderabad, Telangana, India |
| Susaah Laboratories Private Limited | ₹16.82 Cr (FY 2025) | •••• | •••• | -49.0% | •••• | Secunderabad, Telangana, India |
| Sai Sreyas Pharmaceutical Private Limited | ₹16.62 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Zefe Labs (I) by revenue in the Chemicals industry (API Manufacturers, Aromatics), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Zefe Labs (I) Private Limited
Zefe Labs (I) Private Limited is audited by Sandeep Surendra Jain & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Sandeep Surendra Jain & Co. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Zefe Labs (I) Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Zefe Labs (I) Private Limited
Open charges
₹4.39 Cr
Satisfied charges
₹4.6 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2025 | Others | ₹4.12 Cr | Open |
| 19 Jan 2021 | Others | ₹12 Lakh | Open |
| 28 May 2015 | Others | ₹15 Lakh | Open |
| 18 Nov 2024 | Axis Bank Limited | ₹1.5 Cr | Satisfied |
| 25 May 2023 | Axis Bank Limited | ₹1.5 Cr | Satisfied |
Total charge records: 6 View all charges
MSME Payment Delays by Zefe Labs (I) Private Limited
Zefe Labs (I) Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 9 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Synergene Active Ingredients Private Limited | •••• | •••• | •••• |
| Elixir Pharma | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Zefe Labs (I) Private Limited
Employment history and EPFO contributions of people linked to Zefe Labs (I).
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Zefe Labs (I) Private Limited
Zefe Labs (I) Private Limited has 8 board changes on record since 2007: 3 appointments and 5 cessations. The latest: Gurmeet Singh Toor ceased to be Director on 01 Oct 2016.
AGM
Zefe Labs (I) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 412.00 Lakh registered on 28 Jun 2025 with Charge ID 101135030 was modified on 21 Aug 2025.
Charges
A charge registered on 18 Nov 2024 via Charge ID 101017706 with Axis Bank Limited was fully satisfied on 19 Aug 2025.
Charges
A charge registered on 25 May 2023 via Charge ID 100726749 with Axis Bank Limited was fully satisfied on 18 Aug 2025.
Charges
A charge with Others amounted to Rs. 412.00 Lakh with Charge ID 101135030 was registered on 28 Jun 2025.
Filing
Zefe Labs (I) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Axis Bank Limited of Rs. 150.00 Lakh registered on 18 Nov 2024 with Charge ID 101017706 was modified on 16 Jan 2025.
Charges
A charge registered on 06 Jun 2013 via Charge ID 10435529 with Others was fully satisfied on 23 Dec 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 150.00 Lakh with Charge ID 101017706 was registered on 18 Nov 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 150.00 Lakh with Charge ID 100726749 was registered on 25 May 2023.
Charges
A charge with Others of Rs. 160.00 Lakh registered on 06 Jun 2013 with Charge ID 10435529 was modified on 03 Mar 2023.
Charges
A charge with Others amounted to Rs. 12.00 Lakh with Charge ID 100414108 was registered on 19 Jan 2021.
11 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Zefe Labs (I) Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Zefe Labs (I) Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Zefe Labs (I) Private Limited
Zefe Labs (I) has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAACZ3712B1ZY | Madhya Pradesh | Active | 01 Jul 2017 |
| 02AAACZ3712B1Z2 | Himachal Pradesh | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Zefe Labs (I) Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zefe Labs (I) Private Limited
Zefe Labs (I) is an active private limited company based in Indore, Madhya Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 25 April 2007 (19+ years old) and is registered under CIN U74110MP2007PTC019484.
Zefe Labs (I) reported revenue of ₹17.05 Cr for FY 2025 (down 32% YoY).
Zefe Labs (I) has 3 current directors:
- Gurmeet Singh Toor - Whole-Time Director
- Sukhwinder Kaur Toor - Whole-Time Director
- Manjit Singh Bhullar - Whole-Time Director
Zefe Labs (I) reported a net profit of ₹8.19 Lakh (net margin 0.5%) and EBITDA of ₹47.02 Lakh (EBITDA margin 2.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Zefe Labs (I) is -14% over three years and 1% over five years. In the latest year (FY 2025) revenue fell 32%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Zefe Labs (I) is 23AAACZ3712B1ZY, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AAACZ3712B1Z2 (Himachal Pradesh).
The CIN (Corporate Identification Number) of Zefe Labs (I) is U74110MP2007PTC019484. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zefe Labs (I) was incorporated on 25 April 2007, making it 19+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Zefe Labs (I) by revenue are Sreepathi Lab Private Limited, Rangodadhi Chemicals Private Limited, Three A Chemie Private Limited, Hermes Laboratories Private Limited, Seth Brothers (Perfumers ) Private Ltd and 5 more, all in the Chemicals industry (API Manufacturers, Aromatics).
Gurmeet Singh Toor ceased to be Director on 01 Oct 2016. Manjit Singh Bhullar ceased to be Director on 01 Oct 2016. Sukhwinder Kaur Toor ceased to be Director on 01 Oct 2016. Zefe Labs (I) has 8 board changes on record in total.
Yes, Zefe Labs (I) is registered as a small enterprise under Udyam registration (number: UDYAM-MP-23-0028279).
Zefe Labs (I) has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 9 overdue payments to 2 micro and small suppliers. The latest return was filed on 09 Jun 2019.